PillRx only · Tablet, Film Coated · Oral
Saxagliptin
Saxagliptin Hydrochloride
3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
3 active makers
3 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 12 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$1.090
Latest avg · Jul 22, 2026
-56%
Since Dec 17, 2025
3
Active US suppliers
79%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
2.7K
Rx · 2026 Q1
112K
Units dispensed
+17%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Aurobindo Pharma Limited | unknown | 8 | SUPPLYING |
| Glenmark Pharmaceuticals Inc., USA | unknown | 7 | SUPPLYING |
| Mylan Pharmaceuticals Inc. | unknown | 4 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Mar 13, 2025RECALLRecall (Class II): Saxagliptin Tablets 5mg, a). 30-count bottle (NDC# 68462-727-30) b.) 90-count bottle ( 68462-727-90), Rx Only, Manufact…
CGMP Deviations — Recalling firm: Glenmark Pharmaceuticals Inc., USA — U.S. Nationwide
- Mar 13, 2025RECALLRecall (Class II): Saxagliptin Tablets, USP, 2.5mg, a). 30-count bottle (NDC# 68462-726-30), b).90-count bottle(NDC# 68462-726-90), Manufa…
CGMP Deviations — Recalling firm: Glenmark Pharmaceuticals Inc., USA — U.S. Nationwide